dichlororibofuranosylbenzimidazole has been researched along with Bloom Syndrome in 1 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
Bloom Syndrome: An autosomal recessive disorder characterized by telangiectatic ERYTHEMA of the face, photosensitivity, DWARFISM and other abnormalities, and a predisposition toward developing cancer. The Bloom syndrome gene (BLM) encodes a RecQ-like DNA helicase.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kapp, LN | 1 |
| Painter, RB | 1 |
1 review available for dichlororibofuranosylbenzimidazole and Bloom Syndrome
| Article | Year |
|---|---|
DNA replication fork movement rates in mammalian cells.
Topics: Animals; Autoradiography; Bloom Syndrome; Cell Line; Cell Transformation, Neoplastic; Centrifugation | 1982 |